NCT05400122 2025-11-12Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in CancerCase Comprehensive Cancer CenterPhase 1 Suspended12 enrolled
NCT00020267 2024-03-04Vaccine Therapy in Treating Patients With Metastatic CancerNational Cancer Institute (NCI)Phase 1 Completed
NCT05395052 2023-09-21FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid TumorsFate TherapeuticsPhase 1 Terminated5 enrolled
NCT03841110 2023-05-01FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid TumorsFate TherapeuticsPhase 1 Completed37 enrolled